Devic's Syndrome
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders (NCT02249676) | Tianjin Medical University General Hospital | 2013-01-01 |
| Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone (NCT00004645) | National Institute of Neurological Disorders and Stroke (NINDS) | 1995-01-01 |
Track Devic's Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.